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WHEN oestrone was substituted after ovariectomy in breeding female mice
of the RIIIf strain (formerly RIIIb) freed from milk-factor, the proportion of
benign and of the only malignant tumour encountered was comparable with that
in intact breeders in old age (Pullinger, 1955). The effect of substitutcd oestrone
and progesterone on mammary incidence in virgin females spayed at various ages
has now been examined. Among animals in which no interval longer than 1 month
was allowed to elapse between ovariectomy and the beginning of hormone treat-
ment, mammary carcinoma and adenoma arose in the same proportion of animals
as in normal breeders of 3 or more litters. No intact unmated females have
developed mammary carcinoma nor have any that were spayed without subse-
quent hormone treatment. The removal of 1 ovary and partial excision of the
other according to the method ofLipschutz (1925) was followed by the appearance
of 1 mammary carcinoma in 30 females.
METHODS
The mouse strain (RIIIf, formerly RIIIb) was cross-suckled in 1944 and
tested for the continued presence of milk-factor by the injection of extracts of
2 mammary tumours into F1 hybrids of the strain with mothers of a C57 black
subline in which mammary tumours were unknown. No tumours arose in the
test mice (Pullinger, 1952). Examination of mammae and the method of ovariec-
tomny were the same as previously described (Pullinger, 1947, 1949a). Only pure
line progeny were used and pedigree recording has been done by the author
personally. Ovaries were removed at stated intervals after birth. The operation
site was examined at post mortem to ascertain that the ovaries had in fact been
removed or, in the case of the Lipschutz operation, that a portion of 1 ovary
remained. Periodical cornification tests were done. After complete ovariectomy,
hormone was substituted immediately or after a stated interval. Hormones were
applied in measured doses in acetone solution to the skin of the back from which
hair was clipped as required throughout the period oftreatment. Doses of 0.05 ml.
were applied weekly for 20 to 60 weeks or bi-weekly when both oestrone and
progesterone were used. At least 4 months were usually allowed to elapse before
mammae were examined to ensure regression of physiological response. With a
few exceptions that died at 19 months of age, only those animals that lived to at
least 20 months are included in the results. Since 1954, streptomycin, 0.025 per
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the drinking water on 8 occasions for 1 to 3 weeks, in order to combat epidemics
of Tyzzer's disease. In this it has been successful.
RESULTS
No return of oestrus cycles was noted in vaginal cornification tests done at
intervals after ovariectomy at 2 months of age. No macroscopic enlargement of
adrenals was seen in any of the spayed mice. Results of incidence of mammary
adenoma and carcinoma together with treatment are given in Table I. The
TABLE I.-Incidence of Mammary Adenoma and Carcinoma in Ovariectomised
RIIIf Virgin Female Mice Treated with Ovarian Hormones
Number of growths
11 -K
roup
Number Age
of spayed in
mice months
roC}
Treatment.
Time
Dose applied
in mg. of in
hormones months
1 ' * 11 . --
2 20 . 2 . None
3 20 . 2 . Oestrone
0-285-0-30
4 17 . 2 . Oestrone
0-15
5 10 . 5-7 . Ditto
6 24 9-11 Oestrone
0- 1-0-15
Oestrone
~7 14 2 ~0-285-0-305 * 14*2 Progesterone
2-70-2-80
Oestrone
8 . 13 10-11 Progesterone Progesterone
1.5
9 22 . 11 None
Partial
ovariectomy
10 . 21 11
11 . 9 . 6
None
,, 5
2-16
Adenoma
C- -~
Active
squamous
Inactive and
Acinar squamous mixed
2 0 1
0 0 0
3 0 1
Carci-
noma Total
0 3
0
0 0
0 4
10-16 2 0 0 0 2
10-16 1 0 0 0 1
10-16 9 0 3 1 13
2-16 . 2 3 3 1 9
11-16 3 0 0 0 3*
- 4 0 0 0 4
- 1 1
- O -
* 11 only examined for adenoma.
means that either no observation or no treatment was made.
neoplastic changes recorded appeared in otherwise completely involuted glands.
The numbers in each group are small but the results taken together appear
consistent. More than one-third of the mice started in these tests failed to survive
for the whole period. The incidence of the lymphoma-leukaemia group of diseases
has increased in untreated mice ofthis strain. As is well known, ovarian hormones
augment this tendency which caused many losses.
Adenoma
No mammary tumours of any kind occurred in mice ovariectomised at 2 months
in which no hormone was substituted (Group 2). No inactive squamous focus
Cl
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was found in unmated females at any age and this absence is conspicuous in
ovariectomised mice with substituted oestrone alone (Groups 3, 4, 5 and 6). In
Group 7, which was given progesterone as well, inactive squamous foci developed.
To relate these foci to progesterone action would require larger numbers.
Excluding the latter lesions, the overall incidence of adenoma corresponds closely
withthatofbreederswiththeexception ofthosebreedersthatwereneversegregated.
Carcinoma
No mnalignant mammary tumour was found in 32 unmated females that lived
to 20 months or more, nor in any completely ovariectomised female not treated
with hormone. Of 24 unmated females spayed at 9 to 11 months and treated with
oestrone (Group 6) one, ovariectomised at 9 months, developed in the fourth left
nipple area a mammary carcinoma which was first visible and palpable at 19
months of age. Grafts from it grew in 8 out of 8 intact RIIIf males. The total
dose of oestrone was 0.15 mg. The tumour was a cribriform adenocarcinoma
producing much secretion in cystic and acinar structures. There were many
haemorrhagic regions. The rest of the mammary gland was completely involuted
and no benign adenomas were found. There was typical brown degeneration in
adrenals and no hyperplasia. There was no pituitary enlargement.
Of 14 survivors of 23 females in which oestrone and progesterone were substi-
tuted (Group 7) one, ovariectomised at 2 months, developed a mammary tumour
first seen at 19 months of age. Grafts from it grew in 4 out of 4 intact RIIIf
males. It was a soft haemorrhagic growth lying over the third right nipple region
and invading the muscle which separates this and the second nipple area. The
total dose of oestrone was 0.295 mg. and ofprogesterone 2-70 mg. It was a malig-
nant adenoacanthoma. The rest of the mammary gland had well-developed but
involuted duct systems. No adenomas were found. There was brown degeneration
but no hyperplasia in the adrenals. The kidneys and liver contained foci of
lymphoma cells. There was no pituitary enlargement.
Of 21 unmated partially ovariectomised females which had subsequently
undergone oestrus cycles with characteristic profuse secretion, one was found at
post mortem at 20 months of age to have a carcinoma in a second nipple region.
It was an adenocarcinoma and was niot grafted.
COMMENT
Mammary carcinoma was found previously in 2 to 3 per cent ofintact breeding
females over 1 year old that had had at least 3 pregnancies. Substitution in later
life of known doses of oestrone after ovariectomy resulted in the same incidence
(Pullinger, 1955). Substitution of known amounts of oestrone with or without
progesterone in ovariectomised unmated females over the breeding period replaced
the effective factor of 3 pregnancies. In Groups 3, 6, 7 and 8 taken together, in
which the interval between spaying and treatment was never more than 1 month
the same incidence of carcinoma was found. To these 71 females another 8, which
lived beyond the end of treatment to 18 months of age must be added for
comparison with breeders of over 1 year old. The comparative figures for
mammary carcinoma in intact breeders, ovariectomised breeders and unmated
females with substituted hormone are 12 in 482, 1 in 31 and 2 in 79 or 1 in 40,
I in 31 and 1 in 39,
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No evidence was found to suggest that milk factor was present to account for
these carcinomas. Every endeavour has been made to breed sublines derivedfrom
those females or their litter-mates which had developed mammary tumours.
There has been no increase in incidence of either adenomas (hyperplastic nodules)
or malignant tumours in the progeny of two sublines with this ancestry.
Owing to the numbers of mice required for these experiments only 1 dose
level could be tested. This dose was based on the results of an attempted assay,
(Pullinger, 1949b) in which acinar development was found in half the animals
treated with a single dose of 50 ,ug. oestrone. This amount applied by Gardner
(1941) prevented development of rudiments of C3H males with milk factor and
gave a lower incidence of tumours than did 10 jg. For this reason more than
one known dose level requires to be tested. The combined effect of all ovarian
hormones might give other results.
SUMMARY
The incidence of benign and malignant mammary tumours in unmated RIIIf
females after ovariectomy and substituted oestrone was the same as that seen in
breeders of 3 or more litters of this strain.
REFERENCES
DMOCHOWSKI, L.-1953) Brit. J. Cancer, 7, 75.
GARDNER, W. U.-(1941) Endocrinology, 28, 53.
LIPSCHUTZ, A.-(1925) Brit. J. exp. Biol., 2, 331.
PULLINGER, B. D.-(1947) Brit. J. Cancer, 1, 177.-(1949a) Ibid., 3, 494.-(1949b)
Lancet, ii, 823.-(1952) Brit. J. Cancer, 6, 69.-(1955) Ibid., 9, 613, 620.